Table 1 Workshop participants
From: The future of cancer immunotherapy for brain tumors: a collaborative workshop
Name | Affiliation | Location |
|---|---|---|
David Anderson | VBI | MA |
David Andrews, MD | Imvax | PA |
Terri Armstrong, PhD, ANP-BC, FAAN, FAANP | National Institutes of Health Intramural Research Program | MD |
David Arons, JD | National Brain Tumor Society | MA |
Amy Barone, MD | US Food and Drug Administration | MD |
Diana Bradford, MD | US Food and Drug Administration | MD |
Christine Brown, PhD | City of Hope | CA |
Samantha Bucktrout, PhD | Parker Institute for Cancer Immunotherapy | CA |
Alexandra Butler, MD | Patient Advocate | OR |
Lisa Butterfield, PhD | Parker Institute for Cancer Immunotherapy | CA |
Ari Britton, MSc | Parker Institute for Cancer Immunotherapy | CA |
Yan Chen, PhD | Elpis Biopharmaceuticals | MA |
Tim Cloughesy, MD | University of California Los Angeles | CA |
Bob Dillman, MD | AIVITA Biomedical | CA |
Ute Dugan, MD, PhD | Parker Institute for Cancer Immunotherapy | CA |
Brett Ewald, PhD | DNAtrix | CA |
Justin Fairchild, MPH | Parker Institute for Cancer Immunotherapy | CA |
Olga Futer, PhD, PMP | National Brain Tumor Society | MA |
Evanthia Galanis, MD | Mayo Clinic | MN |
Katie Germain | National Brain Tumor Society | MA |
Dan Getts, MBA, PhD | Myeloid Therapeutics | MA |
Pier Federico Gherardini, PhD | Parker Institute for Cancer Immunotherapy | CA |
Mark Gilbert, MD | National Institutes of Health Intramural Research Program | MD |
Sangeeta Goswami, MD, PhD | MD Anderson Cancer Center | TX |
Natalie Greco, PhD | Parker Institute for Cancer Immunotherapy | CA |
Melinda Griffith, JD | Parker Institute for Cancer Immunotherapy | CA |
Thomas Halkin | National Brain Tumor Society | MA |
Jen Haslip | Parker Institute for Cancer Immunotherapy | CA |
Amy Heimberger, MD | Northwestern Medicine | IL |
Adilia Hormigo, MD, PhD | Mount Sinai | NY |
John Infanti, MPA | Parker Institute for Cancer Immunotherapy | CA |
Hilary Keeley, JD | The Sontag Foundation | FL |
Lacey Kitch, PhD | Parker Institute for Cancer Immunotherapy | CA |
Theresa LaVallee, PhD | Parker Institute for Cancer Immunotherapy | CA |
Barbara Lavery | ACGT Foundation | CT |
Danielle Leach, MPH | National Brain Tumor Society | MA |
Michael Lim, MD – | Stanford Medicine | CA |
Wendell Lim, PhD | University of California San Francisco | CA |
Sara Siebel Marr, MS | Parker Institute for Cancer Immunotherapy | CA |
Clair Meehan, MEM | National Brain Tumor Society | MA |
Duane Mitchell, MD, PhD | University of Florida | FL |
W. Garrett Nichols, MD, MS | Istari Oncology | NC |
Hideho Okada, MD, PhD | University of California San Francisco | CA |
Derek Oldridge, MD, PhD | University of Pennsylvania | PA |
Donald O’Rourke, MD | University of Pennsylvania | PA |
Jeremy Pivor | Patient Advocate | MA |
Janine Pixley, MFA, CFRE | Parker Institute for Cancer Immunotherapy | CA |
Robert Prins, PhD | University of California Los Angeles | CA |
Raj Puri, MD, PhD | US Food and Drug Administration | MD |
Christophe Quéva, PhD | Oncorus | MA |
David Reardon, MD | Dana-Farber Cancer Institute | MA |
Joan Robbins, PhD | DNAtrix | CA |
Kole Roybal, PhD | University of California San Francisco | CA |
Daniel Ryan | The Sontag Foundation | FL |
Wendy Selig | WSCollaborative | VA |
Jeffrey Skolnik, MD | Inovio Pharmaceuticals | CA |
William Smith, PhD, JD | Parker Institute for Cancer Immunotherapy | CA |
Jessica Sorrentino, PhD | Istari Oncology | NC |
Marko Spasic, MD | Parker Institute for Cancer Immunotherapy | CA |
Tresa Spencer, PhD | Patient Advocate | TX |
Katherine Szarama, PhD | Emerson Collective | CA |
Kirk Tanner, PhD | National Brain Tumor Society | MA |
Reena Thomas, MD, PhD | Stanford Medicine | CA |
William Timmer, PhD | National Cancer Institute | MD |
Leo Wang, MD, PhD | City of Hope | CA |
Patrick Wen, MD | Dana-Farber Cancer Institute | MA |
Jingying Xu, PhD | Parker Institute for Cancer Immunotherapy | CA |
Alfred Yung, MD | MD Anderson Cancer Center | TX |